Article metrics

Download PDFPDF

4CPS-031 The primary efficacy endpoint for alirocumab, reductions in low-density lipoprotein cholesterol
Free

 

Online download statistics by month:

Online download statistics by month: March 2019 to January 2024

AbstractFullPdf
Mar 2019704
Apr 2019201
May 201930202
Jun 201934202
Jul 20194802
Aug 2019302
Sep 2019300
Oct 2019600
Nov 2019602
Dec 2019401
Jan 2020701
Feb 2020502
Mar 2020603
Apr 2020401
May 20201604
Jun 20201600
Jul 20201203
Aug 2020200
Sep 2020801
Oct 2020402
Nov 2020601
Dec 2020402
Jan 20211400
Feb 2021802
Mar 2021602
Apr 2021501
May 2021002
Jun 2021003
Jul 2021002
Aug 2021004
Sep 2021002
Oct 20219016
Nov 20212011
Dec 2021606
Jan 20221001
Feb 2022600
Mar 20221201
Apr 20221001
May 20221408
Jun 2022606
Jul 20221002
Aug 2022209
Sep 20221008
Oct 2022603
Nov 2022302
Dec 2022600
Jan 2023404
Feb 2023602
Mar 2023900
Apr 2023401
May 2023200
Jun 2023200
Jul 2023403
Aug 2023101
Sep 2023201
Oct 2023500
Nov 2023802
Dec 20232200
Jan 2024202
Total10290144